An example: Eosinophilic airway inflammation as a treatable trait

M. Bafadhel (Oxford, United Kingdom)

Source: ERS Research Seminar 2017 – Precision medicine in airway diseases
Number: 3
Disease area: Airway diseases

Slide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Bafadhel (Oxford, United Kingdom). An example: Eosinophilic airway inflammation as a treatable trait. ERS Research Seminar 2017 – Precision medicine in airway diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Roberto Enrique Díaz García - 19.08.2017 03:22
Excellent
You must Login to comment this presentation.


Related content which might interest you:
Eosinophilic inflammation and asthma control
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009

Modulation of Eosinophilic airway inflammation in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005

Bronchiectasis associated with inflammatory bowel disease
Source: Eur Respir Mon 2011; 52: 163-177
Year: 2011


Eosinophilic inflammation and muscle mass in chronic airway disease
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021


Bronchiectasis and airway eosinophilia in severe asthma—is there an association?
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020


Eosinophilic airway inflammation in COPD and asthma
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008


Eosinophilic refractory inflammation in OCS-dependent severe asthma
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Idiopathic and post-infective bronchiectasis show no clinically important differences in outcomes or airway inflammatory profiles
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015


The pathological feature of airway inflammation in eosinophilic bronchitis
Source: Eur Respir J 2005; 26: Suppl. 49, 282s
Year: 2005

Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms
Source: Eur Respir J 2008; 31: 396-406
Year: 2008



Eosinophilic lung diseases
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

Eosinophilic lung diseases
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

Eosinophilic lung diseases
Source: ERS Skills Course 2016
Year: 2016

Eosinophilic lung diseases
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018




Conclusion: clinical phenotypes of asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005

The clinical features of asthma-COPD overlap syndrome compared to asthma with irreversible airway obstruction
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016